Musa Tariq plans sale of Guardant Health (NASDAQ: GH) common stock

Rhea-AI Filing Summary

Guardant Health, Inc. shareholder Musa Tariq is reported in a Form 144 as intending to sell an amount of 116 common shares through Charles Schwab & Co., Inc. on NASDAQ, with a referenced value of $18,942.00 and an associated date of July 16, 2026.

These securities are described as common stock acquired on July 15, 2026 via a Restricted Stock Lapse, categorized as Equity Compensation. The filing also lists securities sold during the past three months: amounts of 116 with dollar values of $9,840.00, $11,131.00 and $15,102.00 on April 16, May 18 and June 16, 2026, and an amount of 1,951 with a dollar value of $255,893.00 on June 22, 2026.

Key Figures

Amount of common stock to be sold: 116 Referenced value of planned sale: $18,942.00 Prior sale amount on 04/16/2026: 116 and $9,840.00 +3 more

6 metrics

Amount of common stock to be sold 116 Planned sale of Guardant Health common stock through Charles Schwab & Co., Inc.

Referenced value of planned sale $18,942.00 Value associated with the planned sale of 116 Guardant Health common shares

Prior sale amount on 04/16/2026 116 and $9,840.00 Securities sold during the past 3 months for Guardant Health on April 16, 2026

Prior sale amount on 05/18/2026 116 and $11,131.00 Securities sold during the past 3 months for Guardant Health on May 18, 2026

Prior sale amount on 06/16/2026 116 and $15,102.00 Securities sold during the past 3 months for Guardant Health on June 16, 2026

Prior sale amount on 06/22/2026 1,951 and $255,893.00 Securities sold during the past 3 months for Guardant Health on June 22, 2026

Key Terms

Restricted Stock Lapse, Equity Compensation, Securities Sold During The Past 3 Months

3 terms

Restricted Stock Lapse financial

"Common | 07/15/2026 | Restricted Stock Lapse | Guardant Health, Inc."

Equity Compensation financial

"116 | 07/15/2026 | Equity Compensation 144: Securities Sold"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months Musa Tariq"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/16/2026 - 04:03 PM Accepted by SEC EDGAR 07/16/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What stock sale is disclosed for Guardant Health (GH) in this Form 144?

The Form 144 lists a planned sale of 116 common shares of Guardant Health, Inc. through Charles Schwab & Co., Inc., with a referenced value of $18,942.00 and an associated NASDAQ transaction date of July 16, 2026.

How were the Guardant Health (GH) shares to be sold by Musa Tariq acquired?

The shares are described as common stock acquired on July 15, 2026 via a Restricted Stock Lapse, categorized as Equity Compensation, indicating they arose from compensation-related restricted stock that had lapsed.

What prior Guardant Health (GH) sales over the last 3 months does Musa Tariq report?

The filing lists prior sales of amounts of 116 securities with dollar values of $9,840.00, $11,131.00 and $15,102.00 on April 16, May 18 and June 16, 2026, plus 1,951 securities for $255,893.00 on June 22, 2026.

Which broker and market are associated with the planned Guardant Health (GH) sale?

The planned transaction references Charles Schwab & Co., Inc. as the broker and NASDAQ as the market for the sale of 116 Guardant Health common shares with a referenced value of $18,942.00.

Who is the selling security holder named for the Guardant Health (GH) securities?

The Form 144 data identifies Musa Tariq, with an address in Palo Alto, California, in connection with Guardant Health, Inc. securities listed as sold during the past three months and with the planned sale of common stock.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	18942.00	132599929	07/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			116	07/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	04/16/2026	116	9840.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	05/18/2026	116	11131.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/16/2026	116	15102.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	1951	255893.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)